BioAge Labs, Inc. BIOA

US Pharmaceuticals

$5.65 ▼ -0.70% ($-0.04)

Open $5.59

Prev Close $5.69

Day Range $5.55 – $5.85

52W Range $4.81 – $25.96

Market Cap $261.50M

Beta 2.18

EPS (TTM) $-2.39

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2024-09-26
Shares Out.	45,900,000
Website	bioagelabs.com ↗
Phone	15108061445
Employees	62
Revenue	$298,000
Gross Profit	$298,000
Net Income	-$33.5M
Free Cash Flow	-$103.0M
Total Assets	$367.6M
Total Liabilities	$21.2M
Equity	$346.4M

About BioAge Labs, Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

BioAge Labs, Inc. is a publicly traded company under the ticker symbol BIOA on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.